Interestingly enough, in a recently published meta-analysis, the impact of CCND1 expression on OS was a 1.67-fold increased risk for patients with ER-positive breast cancer; however, according to this meta-analysis, CCND1 overexpression does not impact the prognosis of patients with unselected primary breast cancer [30]. Here, CCND1 is linked to breast cancer.